Select Strength — 10ml
For in vitro laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.
Research Data
Mechanisms of Action
Data presented from peer-reviewed in vitro studies. All findings are laboratory observations only.
Bacteriostatic water is the pharmaceutical standard for multi-dose injectable preparations. The 0.9% benzyl alcohol concentration inhibits microbial growth via disruption of bacterial cell membranes, maintaining sterility for 28 days in opened vials — the critical factor for sequential aliquot preparation from peptide stocks.
Bacteriostatic water (0.9% benzyl alcohol USP) maintains sterility in multi-dose vials for up to 28 days after opening — compared to 3–7 days for plain sterile water. The benzyl alcohol prevents microbial growth without affecting peptide solubility or stability.
Analytical Data
| Specification | Value |
|---|---|
| CAS Number | 7732-18-5 |
| Molecular Formula | H₂O + 0.9% C₇H₈O |
| Molecular Weight | 18.015 g/mol |
| Purity (HPLC) | 0.9% Benzyl Alcohol USP% |
| Appearance | Clear sterile aqueous solution |
| Solubility | Universal aqueous diluent |
| Storage | Unopened: 15–25°C · Opened: 2–8°C |
| Shelf Life | 28 days after opening (multi-dose) |
| Research Grade | Yes — For In Vitro Use Only |
What Research Has Shown
USP <797> Pharmaceutical Compounding Standards
Opened Vial Sterility Duration vs. 3–7 Days for Plain Sterile Water
Comparative Activity Profile
In Vitro Safety Data
Bacteriostatic water (0.9% benzyl alcohol USP) is a pharmaceutical-grade preparation meeting USP <797> sterility and pyrogen standards. The 0.9% benzyl alcohol concentration is the established safe limit for multi-dose parenteral preparations as defined by FDA and USP. It is compatible with all lyophilised peptides in the Syntra catalogue.
Observed Adverse Indicators
Adverse events (benzyl alcohol at 0.9%)
lowPeptide compatibility issues reported
lowPyrogen / endotoxin failures (USP batch)
low⚠️ Theoretical Concern
BAC Water is the standard pharmaceutical diluent for multi-dose injectable preparations. USP <797> compliance is verified for every production batch.
Researcher Reference
0.9% benzyl alcohol acts as a bacteriostatic preservative, preventing microbial growth in the vial after opening. This extends opened vial stability from 3–7 days (plain sterile water) to 28 days, allowing multiple aliquots from a single reconstituted vial without contamination risk.
Yes — all injectable peptides in the Syntra catalogue are compatible with bacteriostatic water. The 0.9% benzyl alcohol concentration does not affect peptide solubility, activity, or stability at standard reconstitution volumes.
Unopened: Room temperature 15–25°C. Opened: 4°C, use within 28 days. Do not freeze.
Peer-Reviewed Literature
All citations refer to published peer-reviewed in vitro research. Data presented for scientific reference only. No claims made regarding human therapeutic use.
Enter your email. We send the code. You pay postage. That’s it.
No spam. Unsubscribe any time.